A Food and Drug Administration panel has recommended accelerated approval of the drug Avastin for use in people who have already received treatment for a type of brain cancer. Genentech (DNA ...

Genentech parent Roche has shaved one of five projects from its drug portfolio since Q3 2023. Here’s what that means for the ...

MIAMI, FL — Fifteen Bascom Palmer Eye Institute physicians were selected for the 2024 Power List, a selection of the world’s ...

Now that Genentech has a solid quarter under its belt, investors are waiting to see whether a new use for cancer drug Avastin is effective. has a strong third-quarter earnings report behind it ...

Roche has produced new data showing a combination of Tecentriq and older drug Avastin is more effective than standard therapy for delaying progression in kidney cancer patients. The company’s ...

One of the first things Tauranga mother Shirley Ryder said when she found out about her terminal cancer diagnosis was: “Who’s ...

New research findings presented at this year's ARVO meeting compare two groups of paediatric patients in Nepal ...

Inhibitors of vascular endothelial growth factor — bevacizumab (Avastin) and ranibizumab (Lucentis) — are used to treat patients with neovascular age-related macular degeneration. Bevacizumab ...

In the figure below, the originator monoclonal antibodies losing market share are respectively Herceptin, Rituxan, and Avastin. The future for biosimilars looks promising, too. Analysts from ...

In addition to Leqembi, Biogen’s postpartum depression drug Zurzuvae generated $12 million in quarterly revenues, topping the ...

Anti-angiogenics, like the vascular endothelial growth factor (“VEGF”) inhibitor bevacizumab (Avastin®), have the potential to normalize vasculature and decrease reliance on glycolysis.

What are the conditions under which blood can thicken faster? Dr Rommel Tickoo, director of internal medicine at Max ...